# Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain

> **NCT00813488** · PHASE3 · COMPLETED · sponsor: **Cephalon** · enrollment: 213 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** Fentanyl Buccal Tablet
- **DRUG:** Immediate release oxycodone

## Key facts

- **NCT ID:** NCT00813488
- **Lead sponsor:** Cephalon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-11
- **Final completion:** 2010-01
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2012-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00813488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00813488, "Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00813488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*